Crossmark

Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

Published Online: 2015-09-07

Published Print: 2015-12

Authors

Alavoine, Loubna

Taillé, Camile

Ball, Julie

Knauer, Christine

Witte, Stephan

Kent, Jeffrey

Aubier, Michel
Funding

Funding for this research was provided by:

Horizon Pharma, Inc (formerly Nitec Pharma GmbH) Mannheim, Germany and Deerfield, Illinois, USA
License Information

Text and Data Mining valid from 2015-09-07

Version of Record valid from 2015-09-07
More Information

Article History

Received: 7 July 2015

First Online: 7 September 2015

Document is current